(Total Views: 561)
Posted On: 09/23/2020 11:23:54 AM
Post# of 148988
Hey, y'all. No one answered my question regarding RLFTF. They are our competition. So, I am going to give this a stab. My feeling is that their Phase 2 severe/critical trial either is having enrollment issues or was a bust.
They are requesting EUA based on a 21 patient EIND open-label (retrospective?) study.
Their trial started in May with 144 patients and was supposed to be complete in August and the data was supposed to be available in September (now.) It seems bizarre to me that they are trying to get EUA without this trial data, especially if it is imminent.
It seems like a hail Mary pass to me.
They are requesting EUA based on a 21 patient EIND open-label (retrospective?) study.
Their trial started in May with 144 patients and was supposed to be complete in August and the data was supposed to be available in September (now.) It seems bizarre to me that they are trying to get EUA without this trial data, especially if it is imminent.
It seems like a hail Mary pass to me.
(2)
(0)Scroll down for more posts ▼
